According to a new report, published by KBV research, The Global Vacuum Blood Collection Tube Market size is expected to reach $3.2 billion by 2028, rising at a market growth of 1.8% CAGR during the forecast period.
The Glass segment is showcasing a CAGR of 5.9% during (2022 - 2028). Glass blood collection tubes don't need the use of coagulants; blood coagulation is caused by contact with the glass tube wall. With the exception of its weak alkali stability, glass is often thought of as a fairly stable chemical substance. Due to their resilience, blood collection tubes constructed of glass are often used.
The Blood Routine Examination segment is leading the Global Vacuum Blood Collection Tube Market by Application in 2021 thereby, achieving a market value of $857.1 million by 2028. This is explained by the wide number of ways that vacutainers are used to diagnose diseases. Cells, chemicals, proteins, and other elements in the blood are measured during normal blood tests. These tests can be used to monitor a chronic condition or disease, like as high cholesterol or diabetes, determine whether treatment is having an effect, assess the health of the liver, thyroid, heart, and kidneys, and determine whether the person's immune system is having any difficulties defending against infections.
The Hospitals & Clinics segment ha shown the growth rate of 1.9% during (2022 - 2028). Since hospitals and clinics are so easily accessible in the area, a sizable part of individuals choose to get their medical care there; hence this market is growing. It is anticipated that factors such as increased illness prevalence, changing lifestyles, an increase in surgical and transfusion operations, and the opening of several new diagnostic facilities in emerging nations would provide businesses with significant market possibilities.
The Serum Separating Tubes segment is generating highest revenue share in the Global Vacuum Blood Collection Tube Market by Type in 2021 thereby, achieving a market value of $820.6 million by 2028. This is explained by the benefits of using separation tubes, such as the quick separation of serum from blood's cellular components, the elimination of the need to aliquote serum, the reduction of hazardous substance aerosolization, the shortening of pre-analytical turnaround time, and the ease of transportation. The findings will be greatly affected if the serum for certain analytes, such as glucose, phosphate, and potassium, is not separated within a short period of time.
The North America market dominated the Global Vacuum Blood Collection Tube Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.2 billion by 2028. The Europe market is exhibiting a CAGR of 1.3% during (2022 - 2028). Additionally, The Asia Pacific market would display a CAGR of 2.4% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/vacuum-blood-collection-tube-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Becton, Dickinson and Company, Cardinal Health, Inc., Sekisui Chemical Co., Ltd., Greiner AG, Hindustan Syringes & Medical Devices Ltd., OÜ InterVacTechnology, Advin Health Care, AdvaCare Pharma, MB Plastic Industries, and CML Biotech (P) Ltd.
By Material
By Application
By End-use
By Type
By Geography
Companies Profiled
Unique Offerings 
